Castle Biosciences (CSTL) EBT Margin Growth (3y) (2021 - 2026)
Castle Biosciences (CSTL) EBT Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 266.00 |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -211.00 |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 399.00 |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 28.00 |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -317.00 |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 4,440.00 |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 3,000.00 |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 135.00 |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | -2.00 |
| 10 | Castle Biosciences | 919.57 Mn | 652.76 Mn | 79.85 Mn | 3,579.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,579.00 |
| Mar 31, 2026 | 5,221.00 |
| Dec 31, 2025 | 5,051.00 |
| Sep 30, 2025 | 5,425.00 |
| Jun 30, 2025 | 1,018.00 |
| Mar 31, 2025 | 6,134.00 |
| Dec 31, 2024 | 6,966.00 |
| Sep 30, 2024 | 5,988.00 |
| Jun 30, 2024 | 4,767.00 |
| Mar 31, 2024 | 1,535.00 |
| Dec 31, 2023 | 2,393.00 |
| Sep 30, 2023 | 1,898.00 |
| Jun 30, 2023 | -2,660.00 |
| Mar 31, 2023 | -7,271.00 |
| Dec 31, 2022 | -6,569.00 |
| Sep 30, 2022 | -9,430.00 |
| Jun 30, 2022 | 147.00 |
| Mar 31, 2022 | -7,562.00 |
| Dec 31, 2021 | -9,443.00 |
| Sep 30, 2021 | 4,271.00 |